Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0379 | 1 | 1 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0165 | 0.2773 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0089 | 0.0192 | 0.0693 |
Schistosoma mansoni | serine-rich repeat protein | 0.0089 | 0.0192 | 0.0693 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of SRC assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting | ChEMBL. | 21524503 | |
IC50 (binding) | = 63 uM | Inhibition of IGF-1R assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting | ChEMBL. | 21524503 |
IC50 (binding) | > 100 uM | Inhibition of c-MET assessed as incorporation of p33 using [gammaP33]-ATP by microplate scintillation counting | ChEMBL. | 21524503 |
Ki (binding) | = 606 nM | Displacement of [3H]flumazenil from benzodiazepine receptor in bovine brain membranes | ChEMBL. | 17335185 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.